Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 17 blood brain barrier PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
blood brain barrier PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
We have 17 blood brain barrier PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships
PhD saved successfully
Last chance to apply
Restoring brain health in fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) affects 25% of the population and more than 80% of morbidly obese people. Studies have reported the negative effects that an unhealthy diet and obesity can have on brain function. Read more
Communication of tumour cells with the blood-brain barrier
The blood-brain barrier forms the crucial interface between the systemic circulation and the privileged site of the central nervous system (CNS). Read more
PhD Scholarship to study blood-brain barrier dysfunction in atrial fibrillation
This is an excellent opportunity for a talented and motivated applicant to undertake an original programme of research working within the Brain Barriers Research Group (. Read more
(EPSRC DTP) Developing MRI acquisition and modelling to measure water exchange processes in the brain
Magnetic resonance imaging (MRI) is a non-invasive imaging modality that can produce exquisite images of the brain. Read more
Quantitative MRI measurements to probe brain physiology
Magnetic Resonance Imaging (MRI) can produce exquisite pictures of the brain. It is used to diagnose a variety of neurological diseases. Read more
4 Year PhD with Integrated MSc in Neuroscience: ApoE-ε4 induced blood-brain barrier dysfunction in Alzheimer’s disease
Background. Blood-brain barrier dysfunction in Alzheimer’s Disease (AD). The blood-brain barrier (BBB) is formed by a continuous layer of cerebral endothelial cells held together by tight junction proteins (TJP), which restrict the movement of molecules. Read more
Analysing the factors that regulate expression of blood-brain barrier drug transporter proteins
In order to treat diseases associated with the central nervous system (CNS), e.g. cancer, Parkinson’s disease, depression, it is essential for therapeutic drugs to be able to penetrate into the brain. Read more
Synthesis of novel metal chelators against Parkinson’s Disease (ref: SF22/HLS/APP/TETARD)
The involvement of iron in the development of Parkinson’s Disease is now well recognised. Iron seems to be accumulating in the neurons of sufferers and is involved in the formation of reactive oxygen species that cause oxidative damage to neurons, resulting in their death. Read more
Translational potential of novel mitochondrial-targeted nanoparticles encapsulating hydrogen sulphide as modulators of neurological disease.
Neurodegenerative disorders such as Parkinson’s disease occur due to the progressive and irreversible degeneration of nerve cells. Read more
SELF-FUNDED MSC BY RESEARCH: Modulation of Brain Energy Metabolism by Astrocytic G-protein-coupled Receptors
It has become increasingly clear that ‘neuro’science research must consider the roles of non-neuronal cells in the central nervous system if integrated brain function is to be ultimately understood. Read more
Reaction of brain barriers to chemotherapy
Breakdown of the blood-cerebrospinal fluid (B-CSF) barrier localized in the brain choroid plexus is associated with many neurological disorders. Read more
Peptide-based nanoparticles for brain targeted gene delivery
Gene therapy has the potential to provide therapeutic benefit to millions of people with neurodegenerative diseases and cancer. Delivery into the brain is hampered by the blood-brain barrier (BBB), which limits the efficacy of both conventional and novel therapies at the target site. Read more
MSC BY RESEARCH: Involvement of astrocytes in neurological manifestations of Long COVID syndrome
A significant fraction of patients affected by Long COVID, long-term consequences following acute SARS-CoV-2 infection, suffer from mental fatigue and cognitive deficits (1-3). Read more
Hybrid antioxidant nanocarriers for the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is a neurodegenerative disorder that yearly affects 50 million people worldwide, a number estimated to grow to 139 million in 2050. Read more
Mathematical modelling of cavitation development for October 2023 entry
Background to the Project. Cavitation generation has been much of a mystery for more than a century. A core unresolved challenge is how bubble growth subject to acoustic forcing occurs over millions of cycles of oscillation, which cannot be simulated by any CFD packages. Read more
- 1
- 2